Usona Institute is recruiting for the uAspire clinical trial, which is studying a single dose of investigational psilocybin therapy for major depressive disorder. Before you head to ClinicalTrials.gov or contact a study site, take a moment to read the brief self-check below. This page does not collect or store your responses; it’s simply a quick guide to help you decide whether to explore formal screening.
Potential Participant Pre-Screen Quiz:
Learn About the uAspire Study
Investigational Psilocybin Therapy for Major Depressive Disorder
Visit ClinicalTrials.gov for Full Details